Generic Pharmaceuticals Analysis

Amneal Romidepsin FDA Approval: B2B Analysis for BD Teams and Investors

FDA · 6 min

Lundbeck Advances Lu AG09222 After Phase 2 Migraine Data

migraine · 4 min

FDA Approves Oral Nilotinib Tablets for Ph+ CML: A New Era for Treatment

FDA · Ph+ CML · 6 min

Sun Pharma and Organon File HSR, Awaiting Antitrust Clearance

7 min

Cumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M

FDA · 10 min

Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product

U.S. Food and Drug Administration · 10 min